{"id":543105,"date":"2021-05-13T13:10:02","date_gmt":"2021-05-13T13:10:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=543105"},"modified":"2021-05-13T13:10:02","modified_gmt":"2021-05-13T13:10:02","slug":"single-cell-analysis-market-size-to-reach-usd-698-billion-by-2027-with-top-players-like-general-electric-company-fluidigm-corporation-nanostring-technologies-etc","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/single-cell-analysis-market-size-to-reach-usd-698-billion-by-2027-with-top-players-like-general-electric-company-fluidigm-corporation-nanostring-technologies-etc_543105.html","title":{"rendered":"Single Cell Analysis Market Size To Reach USD 6.98 Billion By 2027 With Top Players Like General Electric Company, Fluidigm Corporation, NanoString Technologies, etc"},"content":{"rendered":"
\"Single<\/a><\/p>\n
\n
Reports And Data<\/div>\n<\/div>\n<\/div>\n
The increasing biopharmaceutical and biotechnology industries and the rising technological developments in single-cell analysis products are driving the demand for the market. Single Cell Analysis Market Size \u2013 USD 2.09 Billion in 2019, Market Growth – CAGR of 17.2%, Market Trends \u2013rise in cancer prevalence globally.<\/div>\n

The global Single Cell Analysis Market<\/a> is forecasted to reach USD 6.98 Billion by 2027, according to a new report by Reports and Data. The global Single-Cell Analysis market is forecasted to expand exponentially owing to the increasing biopharmaceutical and biotechnology industries. Furthermore, the market is also anticipated to be driven by the rising technological developments in single-cell analysis products in the forecasted timeline.<\/p>\n

The rising prevalence of cancer globally is anticipated to propel the market growth to a certain extent in the forecasted timeline. One of the biggest causes of death globally is cancer. In the past couple of decades, the condition has undergone substantial growth and is projected to increase exponentially over the forecast timeframe. In 2018, approximately 1,735,350 new cancer cases were identified in the U. S., as per the National Institutes of Health (NIH), and 609,640 individuals died from the disease. Circulatory tumor cells are gaining growing therapeutic attention because they are essential to induce cancer development to be tracked and care modified. In these situations, single-cell sequencing has been used to pursue improved diagnostic and prognostic genetic markers.<\/p>\n

Get a sample of the report @ <\/strong>https:\/\/www.reportsanddata.com\/sample-enquiry-form\/3716<\/a><\/p>\n

The COVID-19 impact:
<\/span>The distribution of Covid-19’s has influenced industrial activities worldwide. Over the weeks, the market has experienced a downturn that can continue in the coming months. The virus led to the implementation of lockdown, which disrupted the asset management program’s workings as the healthcare sector witnessed a collapse in several countries. They were loaded with patients infected by a coronavirus. Millions of people were infected, and thousands of them died, including the healthcare staff. Although the market suffered a significant setback at the time, the industry is bouncing back as there is a greater need for better management and upgrading the medical sector.<\/p>\n

Further key findings from the report suggest<\/span><\/strong><\/p>\n